Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.
about
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsClinical significance of donor-specific human leukocyte antigen antibodies in liver transplantationAntibody Subclass Repertoire and Graft Outcome Following Solid Organ TransplantationMonitoring pharmacologically induced immunosuppression by immune repertoire sequencing to detect acute allograft rejection in heart transplant patients: a proof-of-concept diagnostic accuracy studyDifferential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B CellsMycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosusThe role of B cells in solid organ transplantation.Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipientsThe significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.Renal transplantation dramatically reduces IgA anti-beta-2-glycoprotein I antibodies in patients with endstage renal disease.Is it time to give up with calcineurin inhibitors in kidney transplantation?Does the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients?Towards new avenues in the management of lupus glomerulonephritis.Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.Immunology of idiopathic nephrotic syndrome.mTOR inhibitors and risk of chronic antibody-mediated rejection after kidney transplantation: where are we now?The safety of pharmacological treatment options for lupus nephritis.Maintenance immunosuppressants in the management of antibody-mediated renal allograft rejection: which regimen is best?B Cell Immunity in Solid Organ Transplantation.Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation.Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells.mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.Crimean-Congo hemorrhagic fever nosocomial infection in a immunosuppressed patient, Pakistan: case report and virological investigation.Effect of high-dose ciclosporin on the immune response to primary and booster vaccination in immunocompetent cats.B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naïve B cells.Immunological status of isolated lymphoid follicles after intestinal transplantation.In vitro effect of human serum and fetal calf serum on CD4+ T cells proliferation in response to myelin oligodendrocyte glycoprotein (MOG) in correlation with RBP/TTR ratio in multiple sclerotic patients.Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica.Refractory Autoimmune Hepatitis: Beyond Standard Therapy.Commentary: Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation.Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation.In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity.Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells.CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.Broadening the translational immunology landscape.Increased metallothionein expression reflects steroid resistance in renal allograft recipients.Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings.
P2860
Q26774993-BAFA96EE-4508-4180-8EC8-236C55C7A98FQ26780271-21333E07-DA3A-4468-AE6B-C381D1336A8BQ28076193-A9FA982A-308C-4B54-A631-038F057C7670Q28611470-8DB3E524-132D-4681-A479-8729613E5D6BQ30279164-6620A34A-3A34-4F44-8783-D9D324CF335DQ33766270-A8D4F492-8900-4B88-B23C-A46246E83A67Q33891696-15E65C19-7683-44AC-802B-86CB432869A3Q33960223-BFC22886-C193-4476-9F9B-8965E94C21ACQ35085619-AEB2934F-739D-473A-A3FA-E0C3C906E61BQ35975914-B3D402CA-8997-4E9A-AD0F-8F5126B29781Q37715369-F71C48A9-0AE2-42D3-9F59-4F373A4EF186Q37730681-BBFD4428-DA46-4344-9F4D-71556897D1C3Q38156847-72C83519-BCF1-4AED-BD8A-CC67AB4C885DQ38328785-2AFF9AE3-9727-4214-8525-3849BD2A2E81Q38686467-90CFD6D7-E079-4229-9177-39B4C980ACB4Q38731333-495B5AB8-B0DD-49BF-A475-D34830E8474DQ38815449-DE2FB11C-6982-40EF-B45D-442447A25CCCQ38818479-355385D2-653A-41A3-9B97-DF594CD950FFQ38829637-43BB2723-0FB5-482A-ACE9-6D9C613A86C0Q39045577-A8A30928-8F47-4885-9057-9798585C9FDFQ39101892-EC15984E-37CE-4D73-ABA4-5F3BFA74F1A2Q39221154-28107EED-E0C1-4623-94B7-C7F18AEEDE88Q39550464-F85EF125-1041-4C7F-800E-81D4AB96DF6DQ39642946-D7FB8C45-0189-442C-BBD5-BD8F0D41CB77Q40267214-60B011A6-4B6B-4430-A64D-309771AC9240Q42219151-1A97C851-619F-4950-9E52-616E8BBDCF9DQ42221525-99353FA5-50CD-4E6E-9259-1A68DC0276FAQ42675419-332BE312-5F28-4063-A34A-067CABC095B1Q44851080-979AC7C3-C7E3-4C50-923B-3170ACEA011BQ45832517-975B0897-6B96-4544-8650-0609DF2DF07FQ46408372-CB7E6C39-5BC5-455A-B80F-9E4016736C18Q47098570-A0C700D7-D9C0-4011-9365-80FDC46DB4D0Q47362322-F5077ED2-BEAE-4513-A7FA-A3F6913ACE2DQ48031492-050FFC0F-DEB6-4BAD-A0E0-157D126681A7Q48140331-CC29385F-A41C-475F-976E-E6BC72B52DAFQ49159423-B1D351BA-C752-4949-BE47-AC918DB4249DQ50531944-502AA257-1BD1-4CE4-AB72-DB6CE82BD2D7Q50777385-EFE8052B-8074-4AA9-BCEB-63CAEE6BBB8EQ50911044-BD6C9579-F1FB-44BB-9E2B-1C68AC4EEF96Q52793674-8C542A1B-9574-42CE-8AC8-7AEA27B95C1E
P2860
Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Calcineurin inhibitors affect ...... interfering with T cell help.
@en
Calcineurin inhibitors affect ...... interfering with T cell help.
@nl
type
label
Calcineurin inhibitors affect ...... interfering with T cell help.
@en
Calcineurin inhibitors affect ...... interfering with T cell help.
@nl
prefLabel
Calcineurin inhibitors affect ...... interfering with T cell help.
@en
Calcineurin inhibitors affect ...... interfering with T cell help.
@nl
P2093
P2860
P1476
Calcineurin inhibitors affect ...... y interfering with T cell help
@en
P2093
C van Kooten
D L Roelen
F H J Claas
P2860
P304
P356
10.1111/J.1365-2249.2009.04051.X
P577
2009-11-18T00:00:00Z